| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745702 | Parkinsonism & Related Disorders | 2013 | 7 Pages |
Abstract
Rasagiline was an effective first adjunct therapy in levodopa-treated patients; benefited patients with signs of early “wearing off”; improved all cardinal PD symptoms; and further improved symptoms in patients already receiving other adjunctive dopaminergic treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Lawrence W. Elmer,